{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:18:51Z","timestamp":1792498731045,"version":"4.5.0"},"reference-count":29,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T00:00:00Z","timestamp":1357084800000},"content-version":"vor","delay-in-days":178,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Andrology"],"published-print":{"date-parts":[[2012,7,8]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Chronic prostatitis (CP) due to <jats:italic>Chlamydia trachomatis<\/jats:italic> (Ct) infection has a significant impact on young male fertility, and eradication of Ct infection after antibiotic therapy does not always result in recovery of semen quality. The study aim was to evaluate the effects on fertility parameters of <jats:sc>l<\/jats:sc>\u2010arginine, <jats:sc>l<\/jats:sc>\u2010carnitine, acetyl\u2010<jats:sc>l<\/jats:sc>\u2010carnitine, and ginseng extracts (FERTIMEV) associated with prulifloxacin in patients affected by CP and oligoasthenoteratozoospermia due to Ct infection. Two hundred and six patients with proven Ct genital infection and oligoasthenoteratozoospermia were enrolled in a prospective, randomized, and controlled study. Prulifloxacin (600 mg) was administered daily for 14 days, and patients were divided into 2 groups: group A: antibiotic therapy alone; and group B: antibiotic therapy and additional therapy with FERTIMEV (1 vial daily for 6 months). Microbiological and semen parameter analyses were performed both at enrollment and after 6 months. National Institutes of Health Chronic Prostatitis Symptom Index and International Prostatic Symptom Score questionnaires were applied. Of the 206 patients, 109 were assigned to group A and 97 to group B. At the enrollment time, no differences were reported with regard to clinical, instrumental, and laboratory data. Six months after treatment, statistically significant differences were demonstrated between both groups in terms of sperm concentration (21.3 \u00b1 13.2 millions\/mL vs 11.5 \u00b1 13.2 millions\/mL) (Cohen's <jats:italic>d<\/jats:italic> = 0.61) (<jats:italic>P<\/jats:italic> &lt; .001, df = 2, <jats:italic>F<\/jats:italic> = 62.10) and percentage of motile sperm (42.4% \u00b1 5.2% vs 29.3% \u00b1 11.0%) (Cohen's <jats:italic>d<\/jats:italic> = 1.52) (<jats:italic>P<\/jats:italic>&lt; .001, df = 2, <jats:italic>F<\/jats:italic> = 91.48). In this study treatment with FERTIMEV together with prulifloxacin improved semen parameters in patients with Ct genital infection and oligoasthenoteratozoospermia compared to treatment with prulifloxacin therapy alone.<\/jats:p>","DOI":"10.2164\/jandrol.111.013961","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T09:40:55Z","timestamp":1342172455000},"page":"615-623","source":"Crossref","is-referenced-by-count":24,"title":["Semen Quality in Patients With <i>Chlamydia trachomatis<\/i> Genital Infection Treated Concurrently With Prulifloxacin and a Phytotherapeutic Agent"],"prefix":"10.1002","volume":"33","author":[{"given":"Tommaso","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M. E.","family":"Wagenlehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Mazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Meacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Mondaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Nesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Tiscione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Malossini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1159\/000474438"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1159\/000019784"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1358\/mf.2010.32.1.1423885"},{"key":"e_1_2_5_5_1","volume-title":"Sexually Transmitted Diseases Treatment Guideline","author":"Centers for Disease Control and Prevention"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc906"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01254-X"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2004.04.041"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.12.025"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/652396"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod61.3.575"},{"issue":"4","key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1128\/IAI.66.4.1282-1286.1998","article-title":"Chlamydial infection in inducible nitric oxide synthase knockout mice","volume":"66","author":"Igietseme JU","year":"1998","journal-title":"Infect Immun"},{"key":"e_1_2_5_13_1","first-page":"52","article-title":"Treatment of chronic prostatitis caused by chlamydial and ureaplasmic infection and complicated with male infertilit","volume":"3","author":"Kalinina SN","year":"2010","journal-title":"Urologia"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/4.6.891"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04679-4"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.05.015"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.10.059"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000049840"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000082252.49374.e9"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)66541-X"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.1999.tb01005.x"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2007.00745.x"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8546-5-37"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(02)02383-X"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2004.06.020"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.2592"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07250.x"},{"key":"e_1_2_5_28_1","first-page":"CD001042","article-title":"Cernilton for benign prostatic hyperplasia","author":"Wilt T","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_5_29_1","volume-title":"WHO Laboratory Manual for the Examination of Human Semen and Sperm\u2010Cervical Mucus Interactio","author":"World Health Organization (WHO)","year":"1999"},{"key":"e_1_2_5_30_1","first-page":"383","article-title":"Effect of Lcarnitine and\/or Lacetyl\u2010carnitine in nutrition treatment for male infertility: a systematic revie","volume":"16","author":"Zhou X","year":"2007","journal-title":"Asia Pac J Clin Nutr"}],"container-title":["Journal of Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.2164%2Fjandrol.111.013961","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.2164\/jandrol.111.013961","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T02:08:37Z","timestamp":1698631717000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.2164\/jandrol.111.013961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,8]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7,8]]}},"alternative-id":["10.2164\/jandrol.111.013961"],"URL":"https:\/\/doi.org\/10.2164\/jandrol.111.013961","archive":["Portico"],"relation":{},"ISSN":["0196-3635","1939-4640"],"issn-type":[{"value":"0196-3635","type":"print"},{"value":"1939-4640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,8]]}}}